Produced by The National Diabetes Guidelines Group.
The NZSSD working group, with support of the Ministry of Health, develops national up-to-date and evidence-based guidance for the management of type 2 diabetes in adults that will continue to be updated as evidence and practice changes.
In the new 2023 algorithm, lifestyle management and metformin remain the first-line interventions and the recent shift towards reducing CV, renal risk and obesity are emphasised, in addition to improving glycaemic control.
Specific changes to the updated guidance include the following.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreThe Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications. The aims are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification. For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway for guidance.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.